| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000251175.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.001554462 |
Resistant |
| ENSG00000251175.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017215137 |
Sensitive |
| ENSG00000251175.1 |
Axitinib |
Head and neck squamous cell carcinoma |
0.01456785 |
Sensitive |
